Panacea Biotec's EmulsiPan listed in CEPI Adjuvant Library to support vaccine development
Panacea Biotec Limited has announced the inclusion of its adjuvant, EmulsiPan, in the Coalition for Epidemic Preparedness Innovations (CEPI) Library of adjuvants. This listing aims to support researchers and developers working on vaccines and biotherapeutics.
EmulsiPan is an oil-in-water emulsion adjuvant created through the nano-emulsification of squalene, surfactants, and buffers. Squalene is a naturally occurring biodegradable and biocompatible triterpene hydrocarbon found in plants and humans. EmulsiPan is supplied as a ready-to-use sterile emulsion in 10 mL USP Type I glass vials, intended for research purposes. It is stable for over two years when stored between 2-8°C.
The global market for adjuvants is projected to exceed $4.8 billion by 2028, driven by applications in vaccines and biological therapies, including oncology. Oil-in-water emulsion adjuvants, such as EmulsiPan, are commonly used in commercial vaccines, including influenza vaccines. EmulsiPan's availability without licensing fees provides an accessible option for vaccine developers.
EmulsiPan has been used in various preclinical studies and collaborative research projects. Notably, it was applied in non-human primate challenge studies for Sarbecoronavirus vaccine candidates at the California Institute of Technology (Caltech) and in Betacoronavirus vaccine development programs in partnership with BRIC-Translational Health Science and Technology Institute (THSTI), funded by CEPI. These studies demonstrate its adaptability and effectiveness in vaccine research.
Developed in 2009 and first commercialized as part of Panacea Biotec's H1N1 vaccine, PandyFlu, EmulsiPan has since become a platform adjuvant for multiple vaccine candidates. Panacea Biotec established a cGMP manufacturing facility for EmulsiPan, ensuring consistent quality and regulatory compliance.
The inclusion of EmulsiPan in the CEPI Adjuvant Library confirms it has undergone scientific evaluation and meets standards necessary to support human vaccine development. This listing is expected to increase access for researchers and companies interested in using EmulsiPan for commercial or research applications.
By offering a stable, ready-to-use formulation and removing licensing fees, Panacea Biotec aims to facilitate equitable access to vaccine adjuvants and contribute to global preparedness for future epidemics and pandemics.
Aman Shukla is a post-graduate in mass communication . A media enthusiast who has a strong hold on communication ,content writing and copy writing. Aman is currently working as journalist at BusinessUpturn.com
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Upturn
5 hours ago
- Business Upturn
Dr. Reddy's shares surge 4% after company partners with Alvotech to develop and commercialize Biosimilar to Keytruda
By Aman Shukla Published on June 5, 2025, 09:29 IST Shares of Dr. Reddy's Laboratories rose 4% in morning trade after the company announced a strategic collaboration with Alvotech, a global biotech firm specializing in biosimilars. The two companies will co-develop and manufacture a biosimilar version of Keytruda® (pembrolizumab), a blockbuster immunotherapy drug used to treat various cancers. Keytruda® generated global sales of US$29.5 billion in 2024, highlighting the significant market potential for its biosimilar version. Through this partnership, Dr. Reddy's and Alvotech aim to accelerate development timelines and expand access to affordable cancer treatments across international markets. As part of the agreement, both firms will jointly invest in R&D, manufacturing, and regulatory processes. Each partner retains global commercialization rights, with certain market exceptions, allowing for broad market reach while optimizing operational efficiency. Dr. Reddy's Laboratories shares opened at ₹1,264.20 and at the time of writing, surged to an intraday high of ₹1,303.40, matching the day's low at the opening price. The stock is trading near its 52-week high of ₹1,421.49, significantly above its 52-week low of ₹1,020.00. Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Author or Business Upturn is not liable for any losses arising from the use of this information. Aman Shukla is a post-graduate in mass communication . A media enthusiast who has a strong hold on communication ,content writing and copy writing. Aman is currently working as journalist at
Business Upturn
7 hours ago
- Business Upturn
Dr. Reddy's and Alvotech partner to develop and commercialize Biosimilar to Keytruda
By Aman Shukla Published on June 5, 2025, 08:41 IST Dr. Reddy's Laboratories Ltd., a leading Indian pharmaceutical company, has entered into a strategic collaboration with Alvotech, a global biotech firm specializing in biosimilar medicines. The partnership aims to co-develop, manufacture, and commercialize a biosimilar version of Keytruda® (pembrolizumab), a groundbreaking cancer treatment used for multiple cancer types worldwide. Keytruda® is a highly successful immunotherapy drug, with global sales reaching an impressive US$29.5 billion in 2024. By combining their expertise, Dr. Reddy's and Alvotech plan to accelerate the biosimilar's development timeline and expand its availability across international markets. Under the agreement, both companies will share development costs and responsibilities, ensuring efficient manufacturing and distribution. Each partner retains the right to commercialize the biosimilar globally, with certain exceptions, maximizing reach and impact. 'We are very pleased to enter into this collaboration for pembrolizumab with Dr. Reddy's. This agreement demonstrates Alvotech's ability to leverage its dedicated R&D and manufacturing platform for biosimilars, accelerating the expansion of our pipeline by pursuing growing global markets. It further enables us to increase the availability of cost-effective, critical biologic medications to patients world-wide,' said Róbert Wessman, chairman and CEO of Alvotech. Aman Shukla is a post-graduate in mass communication . A media enthusiast who has a strong hold on communication ,content writing and copy writing. Aman is currently working as journalist at
Yahoo
18 hours ago
- Yahoo
Novak Djokovic on What Wellness Means to Him: 'It's a Daily Practice'
"Hearst Magazines and Yahoo may earn commission or revenue on some items through these links." for Novak Djokovic, wellness is key to his tennis success. As he aims to capture his elusive 25th Grand Slam title, further cementing his place in the tennis history books, he remains focused on his physical and emotional health.. 'Wellness is about balance—physical, emotional, and spiritual,' he tells T&C during his French Open run. The harmony of all three is key for his continued success in the sport; just at Roland-Garros, Djokovic has won three times, most recently in 2023, and captured his first (and only) Olympic gold medal in tennis on Philippe-Chatrier's storied clay courts last summer. In addition, he recently became only the third man to notch 100 match wins at the tournament, following his rivals Rafael Nadal and Roger Federer. 'It's a daily practice of self-awareness and intention,' Djokovic says of his approach to health. 'Whether it's through nutrition, breathing, movement, or stillness. I believe striking harmony in all areas of life can bring much more joy and contentment than focussing on individual elements themselves. To me, wellness shouldn't be about quick gains, it should be a lasting feeling.' In thinking about his wellbeing, Djokovic says, 'consistency and authenticity are key. I prioritize practices that help me stay grounded and energized, like meditation, and spending time in nature. But equally important is emotional wellness—cultivating gratitude, connecting with family, and having a sense of purpose. Wellness supports not just my tennis, but my entire life.' His fervent belief in the power of hollistic health, he says, is what brought him to team up with Aman Resorts. Djokovic says his ethos 'perfectly aligns' with 'Aman's approach to treating body, mind, and spirit.' Last August, the luxury hotel brand announced Djokovic as an official Wellness Advisor, and since, he's been representing Aman on court. 'The vision and mission that the brand and I share are aligned—we speak a common language when it comes to wellness and longevity,' he says. Djokovic's history with the resorts goes way back; he and his wife, Jelena, married at the Aman Sveti Stefan Resort in Montenegro. 'I always found the brand's approach to holistic wellbeing, integrating mind, body, and spirit, resonates with my own lifestyle and philosophy. This partnership allows me to share my learnings and wellness practices from years at the top of professional sport, with the purpose of helping others enhance their lives through intentional, restorative experiences.' As Aman's Global Brand and Wellness Advisor, Djokovic is excited about the new 'Detoxification Programme,' which he designed with Aman's spa and wellness team. 'The Detoxification Programme we've developed together is something I'm deeply proud of,' he says. 'It brings together years of personal exploration into nutrition, mindfulness, movement, and recovery. In fact, everything that is featured I've tried myself at some point in my career, whether during training or in moments of rest—for example my recent visit to Amanpuri in December. I'm looking forward to people experiencing not just physical renewal, but also a deeper emotional and mental reset which his achievable, even in relatively a short space of time. It's a chance to step away from the noise and reconnect with yourself, which I think is essential in today's world.' The program is currently available at seven of Aman's properties. And, upcoming this year, he will be curating his first in-person retreat (date and location still to be announced). Aman's partnership with Djokovic is just one part of their increasing focus on the world of tennis. Last month, they launched 'Aman Tennis Club,' a line of tennis-inspired clothes, at Amanruya, Bodrum, with friends of the brand—including Djokovic himself. 'As everything else that we do with Aman Essentials, we always get inspired by our beloved Aman junkies, loyal customers—by their demands, their lifestyle, and their rhythm,' Kristina Romanova, CEO of Aman Essentials, says. 'We usually don't follow the trends; we focus really on our loyalists. So that was the case with the Aman Tennis Club.' Tennis, she adds, 'is a great game—it's fun and elegant and intellectual. [There are] new studies that prove that playing can reflect on your longevity; tennis players, and racket sports in general, help you to stay in shape but also it makes your brain work in a certain way and definitely reflects on your overall well-being. It's such a great sport.' For aspiring tennis players (playing on the courts of Aman resorts or just in their hometowns), Djokovic's advice is to 'stay open-minded and curious, never stop dreaming and pushing oneself.' He adds tennis players should 'prioritize looking after the body and the mind,' which are both 'equally as important' to succeed. A ready-to-wear fashion and accessories collection, inspired by the tennis tour, is now available to purchase on all Aman properties. Select pieces are also for sale online:$167.00 at at at This summer, Djokovic is looking forward to continue challenging himself and 'push new limits' on the court. But off the court, he's mainly focused on spending time with his family and exploring nature. 'For the past 20 years my ups and downs in sport, I hope, have inspired people around the world in one way or another—whether to pick up a racquet and play tennis, or to believe in their dreams and not give up,' Djokovic says. 'I consider myself an eternal student of life, and this for me has made a great difference.' You Might Also Like 12 Weekend Getaway Spas For Every Type of Occasion 13 Beauty Tools to Up Your At-Home Facial Game
